[REGN] QoQ Quarter Result on 31-Dec-2024 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-Feb-2025
Financial Year
2024
Quarter
31-Dec-2024 [#Q4]
Profit Trend
QoQ- -31.55%
YoY- -20.86%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/24 30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 CAGR
Revenue 3,789,200 3,720,700 3,547,100 3,145,000 3,434,300 3,362,700 3,158,100 12.85%
PBT 958,100 1,493,000 1,628,100 700,700 1,147,600 1,110,800 1,082,900 -7.80%
Tax 40,400 152,400 195,800 -21,300 -12,000 103,000 114,500 -49.90%
NP 917,700 1,340,600 1,432,300 722,000 1,159,600 1,007,800 968,400 -3.50%
Tax Rate -4.22% -10.21% -12.03% 3.04% 1.05% -9.27% -10.57% -
Total Cost 2,871,500 2,380,100 2,114,800 2,423,000 2,274,700 2,354,900 2,189,700 19.70%
Ratio Analysis
31/12/24 30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 CAGR
NP Margin 24.22 36.03 40.38 22.96 33.77 29.97 30.66 -14.48%
Per Share
31/12/24 30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 CAGR
EPS 8.53 12.40 13.25 6.70 10.88 9.48 9.05 -3.85%
EPS Diluted 8.06 11.54 12.41 6.27 10.19 8.89 8.50 -3.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.